Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thasia Woodworth

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|January 26, 2010
Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritisNicolas Frey, Susan Grange, Thasia Woodworth
Arthritis and Rheumatism|December 30, 2009
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alonePatrick Garnero, Elizabeth Thompson, Thasia Woodworth, et al.
Seminars in Arthritis and Rheumatism|April 8, 2017
Clinical meaning and implications of serum hemoglobin levels in patients with rheumatoid arthritisIvan Padjen, Leopold Öhler, Paul Studenic, et al.
Clinical Biochemistry|April 13, 2010
Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?Morten Asser Karsdal, Kim Henriksen, Diana Julie Leeming, et al.
Clinical Rheumatology|January 31, 2026
Rheumatoid arthritis in crisis: investigating the impact of stress on RA flares during the COVID-19 pandemicNicolette T Morris, Thasia Woodworth, Angela Pham, et al.
Lancet (London, England)|March 25, 2008
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialJosef S Smolen, Andre Beaulieu, Andrea Rubbert-Roth, et al.
Arthritis and Rheumatism|May 1, 2007
Longitudinal performance evaluation and validation of fixed-flexion radiography of the knee for detection of joint space lossMichael C Nevitt, Charles Peterfy, Ali Guermazi, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 24, 2018
Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis PatientsVeena K Ranganath, Erin L Duffy, Vikram K Garg, et al.
Rheumatology (Oxford, England)|May 14, 2011
'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is soughtSarah Hewlett, Tessa Sanderson, James May, et al.
Annals of the Rheumatic Diseases|November 27, 2012
Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation studyAatke van der Maas, Elisabeth Lie, Robin Christensen, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|January 26, 2010
Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritisNicolas Frey, Susan Grange, Thasia Woodworth
Arthritis and Rheumatism|December 30, 2009
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alonePatrick Garnero, Elizabeth Thompson, Thasia Woodworth, et al.
Seminars in Arthritis and Rheumatism|April 8, 2017
Clinical meaning and implications of serum hemoglobin levels in patients with rheumatoid arthritisIvan Padjen, Leopold Öhler, Paul Studenic, et al.
Clinical Biochemistry|April 13, 2010
Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?Morten Asser Karsdal, Kim Henriksen, Diana Julie Leeming, et al.
Clinical Rheumatology|January 31, 2026
Rheumatoid arthritis in crisis: investigating the impact of stress on RA flares during the COVID-19 pandemicNicolette T Morris, Thasia Woodworth, Angela Pham, et al.
Lancet (London, England)|March 25, 2008
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialJosef S Smolen, Andre Beaulieu, Andrea Rubbert-Roth, et al.
Arthritis and Rheumatism|May 1, 2007
Longitudinal performance evaluation and validation of fixed-flexion radiography of the knee for detection of joint space lossMichael C Nevitt, Charles Peterfy, Ali Guermazi, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 24, 2018
Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis PatientsVeena K Ranganath, Erin L Duffy, Vikram K Garg, et al.
Rheumatology (Oxford, England)|May 14, 2011
'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is soughtSarah Hewlett, Tessa Sanderson, James May, et al.
Annals of the Rheumatic Diseases|November 27, 2012
Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation studyAatke van der Maas, Elisabeth Lie, Robin Christensen, et al.
Pageof 3